A Phase II, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety and Efficacy of Ipamorelin Compared to Placebo for the Management of Post-Operative Ileus in Patients
The safety and efficacy of ipamorelin in the management of post-operative ileus
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Recovery of GI function
Until hospital discharge
No
Suzan Allen
Study Director
Helsinn Therapeutics (U.S.), Inc
United States: Food and Drug Administration
ST-IPAM-201
NCT00672074
April 2008
December 2009
Name | Location |
---|---|
Cedars Sinai Medical Center | Los Angeles, California 90048-1804 |
William Beaumont Hospital | Royal Oak, Michigan 48073 |
University of Illinois at Chicago | Chicago, Illinois 60612 |
Washington Hospital Center | Washington, District of Columbia 20010 |
University of Colorado Hospital | Denver, Colorado 80262 |
Indiana University Medical Center | Indianapolis, Indiana 46202 |
USC/Norris Cancer Center | Los Angeles, California |
Barnes Jewish Hospital | St. Louis, Missouri 63110 |
Stony Brook University Medical Center | Stony Brook, New York 11794 |
University Hospitals Case Medical Center | Cleveland, Ohio 44106 |
The Christ Hospital | Cincinnati, Ohio 45219 |
Palo Alto Veterans Hospital | Palo Alto, California 94304 |
Denver VA Hospital | Denver, Colorado 80220 |
Cleveland Clinic of Weston | Weston, Florida 33331 |
St. Joseph's Hospital of Atlanta | Atlanta, Georgia 30342 |
Ochsner Medical Center | New Orleans, Louisiana 70121 |
UMass Memorial Healthcare | Worcester, Massachusetts 01605 |
The Pennsylvania State University | Hershey, Pennsylvania 17033 |
St. Joseph Hospital | Tacoma, Washington 98405 |